Journal Articles – NEMA Research

Disclaimer: The papers below are intended for private viewing by the page owner or those who otherwise have legitimate access to them. No part of it may in any form or by any electronic, mechanical, photocopying, recording, or any other means be reproduced, stored in a retrieval system or be broadcast or transmitted without the prior permission of the respective publishers. If your organization has a valid subscription of the journals, click on the DOI link for the legitimate copy of the papers.

Raffa RB, Taylor R Jr, Pergolizzi JV Jr.

Treating opioid-induced constipation in patients taking other medications: Avoiding CYP450 drug interactions J Clin Pharm Ther 2019;44(3):361-371

Pergolizzi JV Jr., Rosenblatt M, Mariano DJ, LeQuang JA

Clinical considerations about opioid withdrawal symptoms Pain Manag 2019; 9(2):111-113

Pergolizzi JV, LeQuang JA, Passik S, Coluzzi F

Using opioid therapy for pain in clinically challenging situations: questions for clinicians Minerva Anesthesiol 2019; 85(8):899-908

Kitzen JM, McConaha JL, Bookser, ML, Pergolizzi JV Jr, Taylor R Jr, Raffa RB

E-cigarettes for smoking cessation: do they deliver? J Clin Pharm Ther 2019;44(4):650-655

Pergolizzi JV Jr, Rosenblatt M, LeQuang JA.

Three years down the road: the aftermath of the CDC guideline for prescribing opioids for chronic pain Adv Ther 2019;36(6):1235-1240

Pergolizzi JV Jr, Taylor R Jr, LeQuang JA, Lara A, Ortiz AH, Iban MAR

Pain Control in Latin America: The Optimized Role of Buprenorphine in the Treatment of Cancer and Noncancer Pain Pain. Pain Ther 8, 187–201 (2019)

Pergolizzi JV, Varrassi G, Paladini A, LeQuang J

Stopping of decreasing opioid therapy in patients on chronic opioid therapy Pain Ther. 2019 Dec;8(2):163-176

DOI: 10.1007/s40122-019-00135-6

Varrassi G, Alon E, Bagnasco M, Lanata L, Mayoral-Royals V, Paladini A, Pergolizzi JV, Perrot S, Scarpignato C, Tolle T

Towards an effective and safe treatment of inflammatory pain: a Delphi-guided expert consensus Adv Ther 36, 2618–2637 (2019)

DOI: 10.1007/s12325-019-01053-x

Pergolizzi JV Jr, Taylor R Jr, LeQuang JA, Bisney J

Tapentadol extended release in the treatment of severe chronic low back pain and osteoarthritis pain Pain Ther 2018;7(1):37-57

Pergolizzi JV Jr., Taylor R, Jr., LeQuang JA, Bisney J. Raffa RB, Pergolizzi F, Colucci D, Batastini L

Driving under the influence of opioids: what prescribers should know J Opioid Manag 2018;14(6):415-427

Pergolizzi, J.V., Annabi, H., Gharibo, C., LeQuang, JA

The Role of Lofexidine in Management of Opioid Withdrawal Pain Ther 2019;8(1)67-78

Raffa RB, Pergolizzi JV Jr, Taylor R Jr, Parker G, Rodenbeck R

Persistence of healthcare-associated (nosocomial) infections due to inadequate hand hygiene: Part 3 – application of human factors engineering to an ozone hand sanitizer Pharmacol Pharm 2018;9:324-330

Raffa RB, Pergolizzi JV Jr, Taylor R Jr, Choudhuri S, Rodenbeck R

Persistence of healthcare-associated (nosocomial) infections due to inadequate hand hygiene: Part 2 – human factors Pharmacol Pharm 2018;9:310-323

Raffa RB, Pergolizzi JV Jr, Taylor R Jr, Choudhuri S, Rodenbeck R

Persistence of healthcare-associated (nosocomial) infections due to inadequate hand hygiene: Part 1 – biological and treatment factors Pharmacol Pharm 2018;9:293-309

Pergolizzi JV Jr, LeQuang JA, Taylor R Jr, Raffa RB

The Place of Community Rescue Naloxone in a Public Health Crisis of Opioid Overdose Pharmacol Pharm 2019, 10, 61-81

DOI: 10.4236/pp.2019.102006

Nalamachu S, Pergolizzi JV Jr, Taylor R Jr, LeQuang JA, Pergolizzi JV 3rd, Raffa RB

Hormone replacement therapy for restoring the HPG axis in pain patients treated with long-term opioid analgesics Pharmacol Pharm 2018;9:473-480

Pergolizzi JV Jr, Ossipov MH, Taylor R Jr, Raffa RB

‘New-look’ opioids: biased ligands Pharmacol Pharm 2018;9:242-249

Pergolizzi JV Jr, Taylor R Jr, Raffa RB

Crisaborole and apremilast: pde4 inhibitors with similar mechanism of action, different indications for management of inflammatory skin conditions Pharmacol Pharm 2018;9:357-381

Raffa RB, Pergolizzi JV Jr, Taylor R Jr., James RP, Pirner M

Differences in the receptor binding profile of lofexidine compared to clonidine Pharmacology & Pharmacy, 2019, 10, 1-10

DOI: 10.4236/pp.2019.101001

Ossipov MH, Pergolizzi JV Jr, Taylor R Jr, Raffa RB

Targets to watch – nerve growth factor (NGF) as a target for the treatment of neuropathic pain Drugs Future 2018;43:655-664

Raffa RB, Pergolizzi JV Jr, Taylor R Jr.

The fist approved ‘deuterated’ drug: a short review of the concept Pharmacol Pharm 2018;9:440-446

Kitzen JM, Pergolizzi JV Jr, Taylor R Jr, Raffa RB

The role of medical literature, clinical trials and experimental research in drug product-injury litigation: a primer with two examples Pharmacol Pharm 2018;9:208-227

Pergolizzi JV Jr, LeQuang JA, Bisney J

Cannabinoid Hyperemesis. Medical Cannabin and Cannabinoids Med Cannabis Cannabinoids 2018;1:73–95

DOI: 10.1159/000494992

Pergolizzi J, Kowalski M, He E

Effectiveness of once-daily extended-release hydrocodone in individuals previously receiving immediate-release oxycodone for chronic pain Pain Med 2018;19(5):967-977

Raffa RB, Pergolizzi JV Jr, LeQuang JA, Taylor R Jr., Colucci S, Annabi MH

The fentanyl family: a distinguished medical history tainted by abuse J Clin Ther. 2018;43(1):154-158

Meissner W, Huygen F, Neugebauer EAM, Osterbrink J, Benhamou D, Betteridge N, Coluzzi F, De Andres J, Fawcett W, Fletcher D, Kalso E, Kehlet H, Morlion B, Montes Pérez A, Pergolizzi J, Schäfer M

Management of acute pain in the postoperative setting: the importance of quality indicators Curr Med Res Opin 2018; 34(1):187-196

Raffa RB, Pergolizzi JV Jr, Taylor R Jr

The rapid-onset antidepressant effect of ketamine: More surprises? J Clin Pharm Ther 2018;43(2):308-311

Pergolizzi JV Jr, LeQuang JA, Taylor R, Raffa RB

Going beyond prescription pain relievers to understand the opioid epidemic: the role of illicit fentanyl, new psychoactive substances and street heroin Postgrad Med 2018. 130(1):1-8

Raffa RB, Pawasauskas J, Pergolizzi JV Jr, Lu L, Chen Y, Wu S, Jarrett B, Fain R, Hill L, Devarakonda K

Pharmacokinetics of oral and intravenous paracetamol (acetaminophen) when co-administered with intravenous morphine in healthy adult subjects Clin Drug Investig. 2018. 38(3):259-268

Pergolizzi JV Jr, Raffa RB, Taylor R Jr, Vacalis S

Abuse-deterrent opioids: an update on current approaches and considerations Curr Med Res Opin 2018;34(4):711-723

Pergolizzi JV J, LeQuang JA, Taylor R Jr, Raffa RB, Colucci D

The role of cannabinoids in pain control: the good, the bad, and the ugly Minerva Anestesiol 2018 84(8):955-969

Pergolizzi JV Jr, Taylor R Jr, LeQuang JA, Raffa RB

Managing severe pain and abuse potential: the potential impact of a new abuse-deterrent formulation oxycodone/naltrexone extended-release products J Pain Res. 2018;11:301-311

Morlion B, Coluzzi F, Aldington D, Kocot-Kepska M, Pergolizzi J, Mangas AC, Ahlbeck K, Kalso E

Pain chronification: what should a non-pain specialist know? Curr Med Res Opin 2018; 34(7):1169-1178

Raffa RB, Pergolizzi JV, Taylor R, Ossipov MH

Nature’s first atypical opioids: kratom and mitragynines J Clin Pharm Ther 2018;43(3):437-441

Pergolizzi JR JV, Taylor R Jr, LeQuang JA, Raffa RB

The role and mechanism of action of menthol in topical analgesic products J Clin Pharm Ther 2018; 43(3):313-319

Pergolizzi JV Jr, Taylor R Jr, LeQuang JA, Raffa RB, Bisney J

Tapentadol extended release in the treatment of severe chronic low back pain and osteoarthritis pain Pain Ther 2018; 7(1):37-57

Pergolizzi JV Jr, Coluzzi F, Taylor R Jr

Transdermal buprenorphine for moderate chronic noncancer pain syndromes Expert Rev Neurother 2018; 23:1-11

Raffa RB, Pergolizzi JV Jr, Taylor R Jr., Ossipov MH

Indirect-acting strategy of opioid action instead of direct receptor activation: dual-acting enkephalinase inhibitors (DENKIs) J Clin Pharm Ther. 2018 Aug;43(4):443-449.

DOI: 10.1111/jcpt.12687

Eke-Okoro UJ, Raffa RB, Pergolizzi JV Jr, Breve F, Taylor R Jr.

Curcumin in turmeric: basic and clinical evidence for a potential role in analgesia J Clin Pharm Ther 2018. 43(4):460-464

Pergolizzi JV Jr, Taylor R JR, LeQuang JA, Raffa RB.

What’s holding back abuse-deterrent opioid formulations? Considering 12 US stakeholders Exp Opin Drug Deliv 2018; 15(6):567-576

Raffa RB, Pergolizzi JV Jr, Taylor R Jr, Ossipov MH

Discovery of folded DNA structures in human cells: potential drug targets J Clin Pharm Ther 2019; 44(1):125-128

DOI: 10.1111/jcpt.12758

Pergolizzi JV Jr, LeQuang JA, Taylor R Jr, Ossipov MH, Colucci D, Raffa RB

Designing safer analgesics: a focus on µ opioid receptor pathways Exp Opin Drug Discov 2018; 13(10)965-972

Pergolizzi JV , Rosenblatt M, Mariano DJ, Bisney J

Tapering opioid therapy: clinical strategies Pain Manag 2018;8(6):409-413

Raffa RB, Pergolizzi JV Jr, Taylor R Jr, Kitzen JM

Sunscreen bans: coral reefs and skin cancer J Clin Pharm Ther. 2018; 44(1):134-139

DOI: 10.1111/jcpt.12778

Pergolizzi JV Jr, LeQuang JA Ba, Taylor R Jr, Raffa RB; NEMA Research Group

The “Darknet”: The new street for street drugs J Clin Pharm Ther. 2017 Dec;42(6):790-792

DOI: 10.1111/jcpt.12628

Tabor A, Pergolizzi JV Jr, Marti G, Harmon J, Cohen B, Lequang JA

Raising Awareness Among Healthcare Providers about Epidermolysis Bullosa and Advancing Toward a Cure J Clin Aesthet Dermatol. 2017 May;10(5):36-48

Pergolizzi JV, Curro FA, Col N, Ghods MP, Vena D, Taylor R, Naftolin F, LeQuang JA

A multicentre evaluation of an opioid patient-provider agreement. Postgrad Med J. 2017 Oct;93(1104):613-617

DOI: 10.1136/postgradmedj-2016-134607

Nassar MS, Hasan A, Chila T, Schueler S, Pergolizzi C, Reinhardt Z, Lord S, De Rita F, Ferguson L, Smith J, Haynes S, O'Sullivan J, Murtuza B.

Comparison of paracorporeal and continuous flow ventricular assist devices in children: preliminary results Eur J Cardiothorac Surg. 2017 Apr 1;51(4):709-714

DOI: 10.1093/ejcts/ezx006

Müller-Schwefe G, Morlion B, Ahlbeck K, Alon E, Coaccioli S, Coluzzi F, Huygen F, Jaksch W, Kalso E, Kocot-Kępska M, Kress HG, Mangas AC, Margarit Ferri C, Mavrocordatos P, Nicolaou A, Hernández CP, Pergolizzi J, Schäfer M, Sichère P.

Treatment for chronic low back pain: the focus should change to multimodal management that reflects the underlying pain mechanisms Curr Med Res Opin. 2017 Jul;33(7):1199-1210

DOI: 10.1080/03007995.2017.1298521

Lin TC, Ger LP, Pergolizzi JV Jr, Raffa RB, Wang JO, Ho ST

Long-term use of opioids in 210 officially registered patients with chronic noncancer pain in Taiwan: A cross-sectional study J Formos Med Assoc. 2017 Apr;116(4):257-265

DOI: 10.1016/j.jfma.2016.10.015

Pasqualucci A., Nadhari MY., Vaidyan KPT., Varrassi G., LeQuang J., Pergolizzi JV., and Paladini A

Role Of Anesthetist In Sedation For Diagnostic Procedures: The Glass Is Half Empty? A Narrative Review SOJ Anesthesiol Pain Manag. 2017 4(2): 1-4

Fleischer BC, Pergolizzi JV, Papagallo M, Taylor R and LeQuang JA

Trigeminal Trophic Syndrome: A Case Report Austin J Anesthesia and Analgesia - Volume 5 Issue 2 - 2017

Pergolizzi. J., Taylor R., LeQuang J., Bisney J., Breve F., Annabi M., Annabi H., and Colucci S.

The Evolution of Abuse-Deterrent Extended-Release Opioid Formulations: Is there a Place in the Armamentarium for More Products? EC Anaesthesia 3.2 (2017): 64-77

Pergolizzi JV, Raffa RB, Taylor R, et al.

Opioid Therapy for Chronic Noncancer Pain: Safe, Effective, Appropriate? Kaye AD, ed. Scientific American Pain Management [online]. Hamilton: Decker; January 2017

Pergolizzi JV Jr, Taylor R, LeQuang JA, Zampogna G, Raffa RB

Concise review of the management of iatrogenic emesis using cannabinoids: emphasis on nabilone for chemotherapy-induced nausea and vomiting. Cancer Chemother Pharmacol 2017 Mar;79(3):467-477

DOI: 10.1007/s00280-017-3257-1

Broglio K, Pergolizzi J, Kowalski M, Lunch SY, HeE, Wen W.

Efficacy and safety of once-daily extended-release (ER) hydrocodone in individuals previously receiving ER morphine for chronic pain Pain Pract. 2017 Mar; 17(3):382-391

Broglio K, Pergolizzi J, Kowalski M, Lunch SY, HeE, Wen W

Long-term effectiveness of once-daily, single-entity, extended-release hydrocodone in patients of ≥ 75 years of age with moderate to severe nonmalignant and nonneuropathic pain Geriatr Nurs. 2017 Jan-Feb; 38(1):39-47

Raffa RB, Taylor R Jr. Pergolizzi JV Jr, Nalamachu S, Edwards ES, Edwards ET

Application of human factors engineering (HFE) to the design of a naloxone auto-injector for the treatment of opioid emergencies Drug Deliver Transl Res. 2017 Feb; 7(1):1-10

Pergolizzi JV, Raffa RB, Marcum Z, Colucci S, Ripa SR

Safety of buprenorphine transdermal system in the management of pain in older adults Postgrad Med. 2017 Jan; 129(1):92-101

Pergolizzi JV Jr, Raffa RB, Pappagallo M, Fleischer C, Pergolizzi J 3rd, Zampogna G, Duval E, Hismeh J, LeQuang JA, Taylor R Jr

Peripherally acting µ-opioid receptor antagonists as treatment options for constipation in noncancer pain patients on chronic opioid therapy Patient Pref Adherence 2017 Jan 17; 11:107-0119

Pergolizzi JV Jr, Taylor R, LeQuang JA, Zampogna G, Raffa RB.

Concise review of the management of iatrogenic emesis using cannabinoids: emphasis on nabilone for chemotherapy-induced nausea and vomiting Cancer Chemother Pharmacol 2017 Mar; 79(3):467-477.

Treatment for chronic low back pain: the focus should change to multimodal management that reflects the underlying pain mechanisms Curr Med Res Opin 2017 Feb 22

DOI: 10.1080/03007995.2017.1298521

Lin TC, Ger LP, Pergolizzi JV Jr. Raffa RB, Wang JO, Ho ST

Long-term use of opioids in 210 officially registered patients with chronic noncancer pain in Taiwan: A cross-sectional study J Formos Med Assoc. 2016 Dec 23

DOI: 10.1016/j.jma.2016.10.015

Pergolizzi, J.V., et al

Pain Specialists Awareness of Topical Analgesics and Their Use in Pain Control: Survey Results. (2016) J Anesth Surg 3(3): 1- 5

Pergolizzi JV, Zampogna G, Robert Taylor Jr, Raffa RB

(2016) Insights into Chronic Postsurgical Pain. Int J Surg Res. 3(5), 55-60

Pergolizzi J, Raffa RB, LeQuang JA.

The Centers for Disease Control and Prevention opioid guidelines: potential for unintended consequences and will they be abused? J Clin Pharm Ther. 2016 Dec; 41(6):592-593

Pergolizzi J, Paladini A, Varrassi G, Raffa RB

Change Pain: Ever Evolving-An Update for 2016 Pain Ther. 2016 Oct 14

Pergolizzi JV Jr, Seow-Choen F, Wexner SD, Zampogna G, Raffa RB, Taylor R Jr.

Perspectives on Intravenous Oxycodone for Control of Postoperative Pain Pain Pract. 2016 Sep;16(7):924-34

DOI: 10.1111/papr.12345

Pergolizzi J, Raffa RB, Zampogna G, Breve F, Colucci R, Schmidt WK, LeQuang JA.

Comments and Suggestions from Pain Specialists Regarding the CDC’s Proposed Opioid Guidelines Pain Pract. 2016 Sep;16(7):794-808

Lin TC, Ger LP, Pergolizzi J, Raffa RB, Wang JO, Ho ST.

Knowledge, Attitude and Practice Survey of Prescribing Opioids for Chronic Noncancer Pain in Taiwan-Comparison of Pain and Non-Pain Physicians Pain Med. 2016 Aug 22. pii: pnw189

Raffa RB, Taylor R Jr, Pergolizzi JV Jr, Nalamachu S, Edwards ES, Edwards ET

Application of human factors engineering (HFE) to the design of a naloxone auto-injector for the treatment of opioid emergencies Drug Deliv Transl Res. 2016 Aug 25

Coluzzi F, Taylor R Jr, Pergolizzi J, Mattia C, Raffa RB

Good clinical practice guide for opioids in pain management: the three Ts – titration (trial), tweaking (tailoring), transition (tapering) Rev Bras Anestesiol. 2016 May-Jun; 66 (3):310-7

DOI: 10.1016/j.bjan.2016.02.008

Coluzzi F, Taylor R Jr, Pergolizzi J Mattia C, Raffa RB, Braz J

Good clinical practice guide for opioids in pain management: the three Ts – titration (trial), tweaking (tailoring), transition (tapering). Anesthesiol. 2016 May-Jun; 66 (3):310-7.

DOI: 10.1016/j.bjane.2014.09.005

Pergolizzi J, Raffa RB, Nalamachu S, Taylor R Jr

Evolution to low-dose NSAID therapy. Pain Manag. 2016 Apr;6(2):175-89

DOI: 10.2217/pmt.15.69

Pergolizzi J, Zampogna G, Taylor R, Gonima E, Posada J, Raffa RB

A Guide for Pain Management in Low and Middle Income Communities. Managing the Risk of Opioid Abuse in Patients with Cancer Pain Front Pharmacol. 2016 Mar 1;7:42

DOI: 10.3389/fphar.2016.00042

Yarlas A, Miller K, Wen W, Lynch SY, Munera C, Dain B, Pergolizzi J, Raffa R, Ripa SR.

Buprenorphine Transdermal System Improves Sleep Quality and Reduces Sleep Disturbance in Patients with Moderate-to-Severe Chronic Low Back Pain: Results from Two Randomized Controlled Trials Pain Pract. 2016 Mar;16(3):345-58

DOI: 10.1111/papr.12281

Li Z, Pergolizzi JV, Huttner RP, Zampogna G, Breve F, Raffa RB

Management of opioid-induced constipation in pregnancy: a concise review with emphasis on the PAMORAs J Clin Pharm Ther. 2015 Dec;40(6):615-9

DOI: 10.1111/jcpt.12331

Nguyen V, Raffa RB, Taylor R, Pergolizzi JV Jr

The role of abuse-deterrent formulations in countering opioid misuse and abuse J Clin Pharm Ther. 2015 Dec;40(6):629-34

DOI: 10.1111/jcpt.12337

Meissner W, Coluzzi F, Fletcher D, Huygen F, Morlion B, Neugebauer E, Pérez AM, Pergolizzi J.

Improving the management of post-operative acute pain: priorities for change Curr Med Res Opin. 2015 Nov;31(11):2131-43

DOI: 10.1185/03007995.2015.1092122

Coluzzi F, Mattia C, Savoia G, Clemenzi P, Melotti R, Raffa RB, Pergolizzi JV Jr.

Postoperative Pain Surveys in Italy from 2006 and 2012: (POPSI and POPSI-2) Eur Rev Med Pharmacol Sci. 2015 Nov;19(22):4261-9.

Pergolizzi JV, Köknel Talu G, Zmponga G, Erdine S, Taylor R, Ayan B, Raffa RB

Maximizing value in opioid utilization: Is oxycodone immediate release a good option for pain management? Agri. 2015;27(1):1-11

DOI: 10.5505/agri.2015.79663

Pergolizzi JV Jr.

New care measures and their impact on pain medicine: One pain specialist’s perspective Postgrad Med. 2015 Aug;127(6):616-22.

DOI: 10.1080/00325481.2015.1054616

Nalamachu SR, Pergolizzi J, Taylor R Jr, Slatkin NE, Barrett AC, Yu J, Bortey E, Paterson C, Forbes WP

Efficacy and Tolerability of Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: A Responder Analysis of 2 Randomized, Placebo-Controlled Trials Pain Pract. 2015 Jul;15(6):564-71

DOI: 10.1111/papr.12218

Pergolizzi JV Jr, Scholten W, Smith KJ, Leighton-Scott J, Willis JC, Henningfield JE.

The unique role of transdermal buprenorphine in the global chronic pain epidemic. Acta Anaesthesiol Taiwan. 2015 Jun;53(2):71-6.

DOI: 10.1016/j.aat.2015.06.001

Pergolizzi JV Jr, Taylor R Jr, Raffa RB.

The Potential Role of an Extended-Release, Abuse-Deterrent Oxycodone/Acetaminophen Fixed-Dose Combination Product for the Treatment of Acute Pain Adv Ther. 2015 Jun;32(6):485-95

DOI: 10.1007/s12325-015-0213-5

Eichenbaum G, Göhler K, Etropolski M, Steigerwald I, Pergolizzi J, Kim M, Vorsanger G

Does tapentadol affect sex hormone concentrations differently from morphine and oxycodone? An initial assessment and possible implications for opioid-induced androgen deficiency J Opioid Manag. 2015 May-Jun;11(3):211-27

DOI: 10.5055/jom.2015.0270

Coluzzi F, Raffa RB, Pergolizzi J, Rocco A, Locarini P, Cenfra N, Cimino G, Mattia C.

Tapentadol prolonged release for patients with multiple myeloma suffering from moderate-to-severe cancer pain due to bone disease. J Pain Res. 2015 May 8;8:229-38

DOI: 10.2147/JPR.S83490

Yarlas A, Miller K, Wen W, Lynch SY, Munera C, Dain B, Pergolizzi JV Jr, Raffa R, Ripa SR

A Subgroup Analysis Found no Diminished Response to Buprenorphine Transdermal System Treatment for Chronic Low Back Pain Patients Classified with Depression. Pain Pract. 2015 Apr 11

DOI: 10.1111/papr.12298

Pergolizzi JV Jr, Taylor R Jr, Raffa RB

Intranasal ketorolac as part of a multimodal approach to postoperative pain. Pain Pract. 2015 Apr; 15(4):378-88

DOI: 10.1111/papr.12239

Coluzzi F, Pergolizzi J, Raffa RB, Mattia C

The unsolved case of “bone-impairing analgesics”: the endocrine effects of opioids on bone metabolism Ther Clin Risk Manag. 2015 Mar 31; 11:515-23

DOI: 10.2147/TCRM.S79409

Pergolizzi JV Jr, Zampogna G, Taylor R Jr, Raffa RB

Long-term efficacy, safety and tolerability of Remoxy for the management of chronic pain. Expert Rev Neurother. 2015 Mar; 15(3):231-8

DOI: 10.1586/14737175.2015.1015418

Pergolizzi JV Jr.

DEA reschedules hydrocodone combination products Pain Pract. 2015 Feb; 15(2):95-7

DOI: 10.1111/papr.12268

Pergolizzi JV, Ben-Joseph R, Chang CL, Hess G.

Predicting medication persistence to buprenorphine transdermal system. Pain Pract. 2015 Feb;15(2):140-9

DOI: 10.1111/papr.12155

Vadivelu N, Gowda AM, Urman RD, Jolly S, Kodumudi V, Maria M, Taylor R Jr, Pergolizzi JV Jr.

Ketorolac tromethamine – routes and clinical implications Pain Pract. 2015 Feb;15(2):175-93

DOI: 10.1111/papr.12198

Pergolizzi JV, Köknel Talu G, Zmponga G, Erdine S, Taylor R, Ayan B, Raffa RB

Maximizing value in opioid utilization: Is oxycodone immediate release a good option for pain management? Agri. 2015 Jan; 27(1):1-11

DOI: 10.5505/agri.2015.79663

Yarlas A, Miller K, Wen W, Lynch SY, Ripa SR, Pergolizzi J, Raffa RB

DOI: 10.1111/papr.12281

Yarlas A, Miller K, Wen W, Lynch SY, Munera C, Pergolizzi J, Raffa R, Ripa SR.

Buprenorphine transdermal system compared with placebo reduces interference in functioning for chronic low back pain Postgrad Med. 2015 Jan; 127(1):38-45

Pergolizzi JV, Gharibo C, Ho KY

Treatment Considerations for Cancer Pain: A Global Perspective Pain Pract. 2014 Dec 3.

DOI: 10.1111/papr.12253

Langley PC, Pergolizzi JV Jr, Taylor R Jr, Ridgway C

Antioxidant and associated capacities of camu (Myrciaria dubia): a systematic review. J Altern Complement Med. 2015 Jan; 21(1):8-14

DOI: 10.1089/acm.2014.0130

Daitch D, Daitch J, Novinson D, Frey M, Mitnick C, Pergolizzi J Jr .

Conversion from high-dose full-opioid agonists to sublingual buprenorphine reduces pain scores and improves quality of life for chronic pain patients Pain Med. 2014 Dec; 15(12):2087-94.

DOI: 10.1111/pme.12520

Ciccozzi A, Angeletti C, Guetti C, Pergolizzi J, Angeletti PM, Mariani R, Marinangeli F

Regional anesthesia techniques for carotid surgery: the state of art J Ultrasound. 2014 May 1; 17(3):175-83

DOI: 10.1007/s40477-014-0094-5

Radnovich R, Chapman CR, Gudin JA, Panchal SJ, Webster LR, Pergolizzi JV Jr

Acute pain: effective management requires comprehensive assessment Postgrad Med. 2014 Jul; 126(4):59-72

DOI: 10.3810/pgm.2014.07.2784

Taylor R, Raffa RB, Pergolizzi JV.

Opioid formulations with sequestered naltrexone: a perspective review Ther Adv Drug Saf. 2014 Jun; 5(3):129-37.

DOI: 10.1177/2042098614526769

Raffa RB, Haidery M, Huang HM, Kalladeen K, Lockstein DE, Ono H, Shope MJ, Sowunmi OA, Tran JK, Pergolizzi JV Jr

The clinical analgesic efficacy of buprenorphine J Clin Pharm Ther. 2014 Dec; 39(6):577-83

DOI: 10.1111/jcpt.12196

Raffa RB, Gudin JA, Nalamachu S, Pergolizzi JV Jr

‘Selective’ COX-1 or COX-2 NSAIDs: time to change a misleading measure J Clin Pharm Ther. 2014 Oct; 39(5):455-6

DOI: 10.1111/jcpt.12192

Galia E, Williams Y, Van Hove B, Pergolizzi J, Etropolski M, Vorsanger G

Evaluation of the tamper-resistant properties of tapentadol extended-release tablets: results of in vitro laboratory analyses J Opioid Manag. 2014 May-Jun; 10(3):149-58

DOI: 10.5055/jom.2014.0203

Nalamachu S, Pergolizzi JV, Raffa RB, Lakkireddy DR, Taylor R Jr.

Drug-drug interaction between NSAIDS and low-dose aspirin: a focus on cardiovascular and GI toxicity Expert Opin Drug Saf. 2014 Jul; 13(7):903-17

DOI: 10.1517/14740338.2014.924924

Müller-Schwefe G, Ahlbeck K, Aldington D, Alon E, Coaccioli S, Coluzzi F, Huygen F, Jaksch W, Kalso E, Kocot-Kępska M, Kress HG, Mangas AC, Ferri CM, Morlion B, Nicolaou A, Hernández CP, Pergolizzi J, Schäfer M, and Sichère P

Pain in the cancer patient: different pain characteristics CHANGE pharmacological treatment requirements Curr Med Res Opin. 2014 Sep; 30(9):1895-908

DOI: 10.1185/03007995.2014.925439

Nalamachu SR, Pergolizzi J, Taylor R Jr, Slatkin NE, Barrett AC, Yu J, Bortey E, Paterson C, Forbes WP

DOI: 10.1111/papr.12218

Antor MA, Uribe AA, Erminy-Falcon N, Werner JG, Candiotti KA, Pergolizzi JV and Bergese SD

The effect of transdermal scopolamine for the prevention of postoperative nausea and vomiting Front. Pharmacol., 09 April 2014

DOI: 10.3389/fphar.2014.00055

Raffa RB, Pergolizzi JV Jr

A modern analgesics pain ‘pyramid’ J Clin Pharm Ther. 2014 Feb; 39(1):4-6

DOI: 10.1111/jcpt.12110

Miller K, Yarlas A, Wen W, Dain B, Lynch SY, Ripa SR, Pergolizzi JV Jr, Raffa R.

The impact of buprenorphine transdermal delivery system on activities of daily living among patients with chronic low back pain: an application of the international classification of functioning, disability and health Clin J Pain. 2014 Dec; 30(12):1015-22

DOI: 10.1097/AJP.0000000000000068

Pergolizzi JV, Pappagallo M, LeQuang J, Labhsetwar S, Taylor R.

New health care measures: emphasis on better management of postsurgical pain and postoperative nausea and vomiting Hosp Pract (1995). 2014 Feb; 42(1):65-74

DOI: 10.3810/hp.2014.02.1093

Pergolizzi JV Jr, Raffa RB, Taylor R Jr.

Treating acute pain in light of the chronification of pain Pain Manag Nurs. 2014 Mar; 15(1):380-90

DOI: 10.1016/j.pmn.2012.07.004

Taylor R Jr, Pergolizzi JV, Raffa RB, Nalamachu S, Balestrieri PJ

Pain and obesity in the older adult Curr Pharm Des. 2014; 20(38):6037-41

Pergolizzi JV Jr, Taylor R Jr, Raffa RB, Nalamachu S, Chopra M.

Fast-Acting Sublingual Zolpidem for Middle-of-the-Night Wakefulness Sleep Disord. 2014; 2014:527109

DOI: 10.1155/2014/527109

Pergolizzi JV Jr, Ma L, Foster DR, Overholser BR, Sowinski KM, Taylor R Jr, Summers KH

The prevalence of opioid-related major potential drug-drug interactions and their impact on health care costs in chronic pain patients J Manag Care Spec Pharm. 2014 May; 20(5):467-76

Pergolizzi JV Jr, Ben-Joseph R, Chang CL, Hess G.

US practitioner prescribing practices and patient characteristics of those newly treated with a buprenorphine transdermal patch system Curr Med Res Opin. 2014 Aug; 30(8):1579-87

DOI: 10.1185/03007995.2014.901941

Vadivelu N, Gowda AM, Urman RD, Jolly S, Kodumudi V, Maria M, Taylor R Jr, Pergolizzi J.

Ketorolac tromethamine – routes and clinical implications Pain Pract. 2015 Feb; 15(2):175-93

DOI: 10.1111/papr.12198

Morley-Forster PK, Pergolizzi JV, Taylor R Jr, Axford-Gatley RA, Sellers EM.

Mitigating the risk of opioid abuse through a balanced undergraduate pain medicine curriculum. J Pain Res. 2013 Dec 4; 6:791-801

DOI: 10.2147/JPR.S47192

Pergolizzi JV Jr, Taylor R Jr, Nalamachu S, Raffa RB, Carlson DR, Varanasi RK, Kopecky EA

Challenges of treating patients with chronic pain with dysphagia (CPD): physician and patient perspectives Curr Med Res Opin. 2013 Oct 28

Raffa RB, Taylor R Jr, Pergolizzi JV Jr

Sequestered naltrexone in sustained release morphine or oxycodone – a way to inhibit illicit use? Expert Opin Drug Saf. 2013 Nov 11

Raffa RB, Pergolizzi JV Jr.

Opioid-induced hyperalgesia: is it clinically relevant for the treatment of pain patients? Pain Manag Nurs. 2013 Sep; 14(3):e67-83

Pergolizzi JV Jr, Lequang JA

Abuse-Deterrent Formulations of Opioid Analgesics Pain Pract. 2013 Aug 6

DOI: 10.1111/papr.12093

Pergolizzi J, Ahlbeck K, Aldington D, Alon E, Coluzzi F, Dahan A, Huygen F, Kocot-Kępska M, Mangas AC, Mavrocordatos P, Morlion B, Müller-Schwefe G,Nicolaou A, Pérez Hernández C, Sichère P, Schäfer M, Varrassi G.

The development of chronic pain: physiological CHANGE necessitates a multidisciplinary approach to treatment Curr Med Res Opin 2013 Jul 3

Angeletti C, Guetti C, Ursini ML, Taylor R Jr, Papola R, Petrucci E, Ciccozzi A, Paladini A, Marinangeli F, Pergolizzi J, Varrassi G

Low Back Pain in a Natural Disaster Pain Pract. 2013 Jun 14

DOI: 10.1111/papr.12087

Summers K, Pergolizzi J, Ma L, Foster D, Overholser B, Sowinski K

The prevalence of opioid-related major potential drug-drug interactions and their impact on health care costs Value Health. 2013 May; 16(3):A12

DOI: 10.1016/j.jval.2013.03.076

Pergolizzi J, Hess G, Chang CL, Shah D, Pierz K, Benjoseph R

Factors predicting medication persistence among patients initiating Buprenorphine transdermal system Value Health. 2013 May; 16(3):A120

DOI: 10.1016/j.jval.2013.03.575

Pergolizzi J, Ben Joseph R, Chang CL, Pierz K, Shah D, Hess G

Impact of dosage strength on medication persistence among patients treated with buprenorphine transdermal system. Value Health. 2013 May; 16(3):A120

DOI: 10.1016/j.jval.2013.03.576

Pergolizzi JV.

Treatment of chronic pain in older people: evidence-based choice of strong-acting opioids. Drugs Aging. 2012 Dec; 29(12):993-5; author reply 997-8

DOI: 10.1007/s40266-012-0025-0

Leslie JB, Raffa RB, Taylor R, Muniz E, Nalamachu S, Pergolizzi JV.

Essential Oxygen Oil for Treatment of Sport-Related Injuries American Journal of Sports Science and Medicine, 2013, Vol. 1, No. 1, 7-12

Merchante I, Pergolizzi J, van de Laar M, Mellinghoff HU, Nalamachu S, O’Brien J, Perrot S, and Raffa RB

Tramadol/Paracetamol Fixed-Dose Combination for Chronic Pain Management in Family Practice: A Clinical Review ISRN Family Medicine, vol. 2013, Article ID 638469, 15 pages, 2013

DOI: 10.5402/2013/638469

Apfel CC, Turan A, Souza K, Pergolizzi J, Hornuss C

Intravenous acetaminophen reduces postoperative nausea and vomiting: a systematic review and meta-analysis Pain. 2013 Jan 11. pii: S0304-3959(13)00009-2.

DOI: 10.1016/j.pain.2012.12.025

Obrien J, Pergolizzi J, van de Laar M, Mellinghoff HU, Moron Merchante I, Nalamachu S, Perrot S, Raffa RB

Fixed-dose combinations at the front line of multimodal pain management: perspective of the nurse-prescriber Nursing: Research and Reviews 2013:3

Pergolizzi JV, Raffa RB, Taylor R, Nagar S, Labhsetwar S, Sinclair N, Gould EM

An open-label pharmacokinetic study of oxymorphone extended release in the presence of naltrexone in the older adult J Opioid Manag. 2012 Nov-Dec; 8(6):383-93

DOI: 10.5055/jom.2012.0138

van Laar M, Pergolizzi JV Jr, Mellinghoff HU, Merchante IM, Nalamachu S, O'Brien J, Perrot S, Raffa RB

Pain treatment in arthritis-related pain: beyond NSAIDs Open Rheumatol J. 2012; 6:320-30.

DOI: 10.2174/1874312901206010320

Taylor R, Pergolizzi JV, Raffa RB.

Tapentadol extended release for chronic pain patients. Adv Ther. 2013 Jan; 30(1):14-27

DOI: 10.1007/s12325-013-0002-y

Pergolizzi JV Jr, Labhsetwar S, Lequang JA.

Compounding Pharmacies: Who is in Charge? Pain Pract. 2013 Jan 28

DOI: 10.1111/papr.12033

Pergolizzi, JV.

Treatment of Chronic Pain in Older People: Evidence-Based Choice of Strong-Acting Opioids Drugs Aging. 2012:12 (29): 993-95.

Pergolizzi J, Taylor R, Plancarte R, Muniz E.

Es la Buprenorfina una buena opción en el manejo de dolor postoperatorio? Rev Soc Esp Dolor 2012; 19(6): X-X

Yarlas A, Miller K, Wen W, Dain B, Lynch SY, Pergolizzi J, Raffa R, Ripa S.

A Randomized, Placebo-Controlled Study of the Impact of the 7-Day Buprenorphine Transdermal System on Health-Related Quality of Life in Opioid-Naïve Patients with Moderate-to-Severe Chronic Low Back Pain The Journal of Pain, Vol 13 No (1), 2013: pp 14-23

Raffa RB, Pergolizzi JV, Muniz E, Taylor R, and Pergolizzi J.

Designing Opioids That Deter Abuse Pain Research and Treatment 2012, Article ID 282981

DOI: 10.1155/2012/282981

Taylor R Jr, Pergolizzi JV, Sinclair A, Raffa RB, Aldington D, Plavin S, Apfel CC

Transversus Abdominis Block: Clinical Uses, Side Effects, and Future Perspectives Pain Pract. 2012 Sep 12.

DOI: 10.1111/j.1533-2500.2012.00595.x.

Pergolizzi, Van de Laar M, Langford R, Mellinghoff HU, Merchante IM, Nalamachu S, O’Brien J, Perrot S, and Raffa RB.

Tramadol/paracetamol fixed-dose combination in the treatment of moderate to severe pain Journal of Pain Research 2012:5 327–346

Daitch J, Frey ME, Silver D, Mitnick C, Daitch D, Pergolizzi J.

Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine Pain Physician. 2012 Jul; 15(3 Suppl):ES59-66

Pergolizzi JV Jr, Philip BK, Leslie JB, Taylor R Jr, Raffa RB.

Perspectives on transdermal scopolamine for the treatment of postoperative nausea and vomiting J Clin Anesth. 2012 Jun; 24(4):334-45

Pergolizzi JV Jr, Gharibo C, Passik S, Labhsetwar S, Taylor R Jr, Pergolizzi JS, Müller-Schwefe G

Dynamic risk factors in the misuse of opioid analgesics J Psychosom Res. 2012 Jun; 72(6):443-51. Epub 2012 Apr 5

Pergolizzi JV Jr, Raffa RB, Taylor R Jr, Rodriguez G, Nalamachu S, Langley P.

A Review of Duloxetine 60 mg Once-Daily Dosing for the Management of Diabetic Peripheral Neuropathic Pain, Fibromyalgia, and Chronic Musculoskeletal Pain Due to Chronic Osteoarthritis Pain and Low Back Pain. Pain Pract. 2012 Jun 21

DOI: 10.1111/j.1533-2500.2012.00578.x

Pergolizzi JV, Raffa RB, Pergolizzi JS, Taylor R.

Non-Analgesic Effects of Opioids: Factors Relevant to Opioid Abuse and Abuse-Deterrent Formulations. Curr Pharm Des. 2012 Jun 28.

Angeletti C, Guetti C, Papola R, Petrucci E, Ursini ML, Ciccozzi A, Masi F, Russo MR, Squarcione S, Paladini A, Pergolizzi J, Taylor R Jr, Varrassi G, Marinangeli F.

Pain after earthquake Scand J Trauma Resusc Emerg Med. 2012 Jun 29; 20(1):43

Raffa RB, Pergolizzi JV Jr.

Is Morphine Medicine’s Biggest Misnomer? Ann Pharmacother. 2012 Jul 3

Taylor R Jr, Raffa RB, Pergolizzi JV Jr

Controlled release formulation of oxycodone in patients with moderate to severe chronic osteoarthritis: a critical review of the literature J Pain Res. 2012; 5:77-87. Epub 2012 Apr 23

Raffa RB, Burmeister JJ, Yuvasheva E, Pergolizzi JV Jr

QTc interval prolongation by d-propoxyphene: what about other analgesics? Expert Opin Pharmacother. 2012 May 9

Raffa RB, Tallarida RJ, Taylor R Jr, Pergolizzi JV Jr

Fixed-dose combinations for emerging treatment of pain Expert Opin Pharmacother. 2012 Mar 16

Pergolizzi J, Raffa R, Taylor R.

Low-dose transdermal buprenorphine system: an update Paineurope 2012: 1; 8-9

Raffa RB, Pergolizzi JV Jr.

Intracerebroventricular opioids for intractable pain Br J Clin Pharmacol. 2012 Feb 1

DOI: 10.1111/j.1365-2125.2012.04201.x

Taylor R, Lemtouni S, Weiss K, Pergolizzi J.

Pain Management in the Elderly: An FDA Safe Use Initiative Expert Panel’s View on Preventable Harm Associated with NSAID Therapy Current Gerontology and Geriatrics Research, vol. 2012, Article ID 196159, 9 pages, 2012

DOI: 10.1155/2012/196159

Raffa RB and Pergolizzi J.

Multi-mechanistic analgesia for opioid-induced hyperalgesia. Journal of Clinical Pharmacy and Therapeutics, 2012, 37, 125–127

Pergolizzi J, Ahlbeck K, Aldington D, Alon E, Collett B, Coluzzi F, Huygen F, Jaksch W, Kocot-Kępska M, Mangas AC, Margarit C, Mavrocordatos P, Morlion B, Müller-Schwefe G, Nicolaou A, Hernández CP, Sichere P, Varrassi G.

The chronic pain conundrum: should we CHANGE from relying on past history to assessing prognostic factors? Curr Med Res Opin. 2011 Dec 19

Taylor R, Raffa R, and Pergolizzi J.

Naltrexone extended-release injection: an option for the management of opioid abuse Substance Abuse and Rehabilitation 2011:2; 219–226

Pergolizzi J.

Quantifying the Impact of Drug-Drug Interactions Associated with Opioids The American Journal of Managed Care. 2011:17 (11). (S) 288-292

Pergolizzi J.

Chronic pain – moving from symptom control to mechanism-based treatment Current Medical Research & Opinion 2011: 27(10): 2079–2080

Blair R, Taylor R, Pergolizzi J, Tabor A.

Clinical Roundup: How Do You Treat Premenstrual Syndrome in Your Practice? Alternative and Complementary Therapies. August 2011, 17(4): 237-246

DOI: 10.1089/act.2011.17401

Varrassi G, Collett B, Morlion B, Kalso E, Nicolaou A, Dickenson A, Pergolizzi J, Schafer M, and Muller-Schwefe G.

Conference report Proceedings of the CHANGE PAIN Expert Summit in Rome, June 2011 Current Medical Research & Opinion 2011: 27 (10): 2061–2062

Pergolizzi J, Alegre C, Blake D, Alén JC, Caporali R, Casser HR, Correa-Illanes G, Fernandes P, Galilea E, Jany R, Jones A, Mejjad O, Morovic-Vergles J, Oteo Álvaro A, Radrigán Araya FJ, Simões ME, Uomo G.

Current Considerations for the Treatment of Severe Chronic Pain: The Potential for Tapentadol Pain Pract. 2011 Jul 29

DOI: 10.1111/j.1533-2500.2011.00487.x

Pergolizzi J, Alon E, Baron R, Bonezzi C, Dobrogowski J, Gálvez R, Jensen T, Kress HG, Marcus MAE, Morlion B, Perrot S, Treede RD.

Tapentadol in the management of chronic low back pain: a novel approach to a complex condition? Journal of Pain Research 2011:4: 203–210

Pergolizzi J, Raffa R, and Taylor R.

Prophylaxis of Postoperative Nausea and Vomiting in Adolescent Patients: A Review with Emphasis on Combination of Fixed-Dose Ondansetron and Transdermal Scopolamine Journal of Drug Delivery Volume 2011, Article ID 426813, 7 pages

DOI: 10.1155/2011/426813

Pergolizzi JV, Raffa RB, Tallarida R, Taylor R, Labhsetwar SA.

Continuous Multimechanistic Postoperative Analgesia: A Rationale for Transitioning from Intravenous Acetaminophen and Opioids to Oral Formulations Pain Pract. 2011 Jun 16

DOI: 10.1111/j.1533-2500.2011.00476.x

Pergolizzi J, Gan TJ, Plavin S, Labhsetwar S, Taylor R,

Perspectives on the Role of Fospropofol in the Monitored Anesthesia Care Setting Anesthesiology Research and Practice, vol. 2011, Article ID 458920

DOI: 10.1155/2011/458920

Pergolizzi J, Taylor R, and Raffa R.

“Extended-release Formulations of Tramadol in the Treatment of Chronic Pain” In Press: Expert Opin Pharmacother. 2011:12 (11)

Pergolizzi, J.

In response: urine drug screening and compliance Pain Pract. 2011 Mar; 11(2):199

DOI: 10.1111/j.1533-2500.2011.00443_2.x

Altorjay A; Melson T; Chinachoit T;Kett A; Aqua K; Levin J; Blackburn LM; Lane S; Pergolizzi JV

Casopitant and Ondansetron for Postoperative Nausea and Vomiting Prevention in Women at High Risk for Emesis: A Phase 3 Study. Arch Surg. 2011; 146(2):201-206

DOI: 10.1001/archsurg.2010.327

Pergolizzi JV, Labhsetwar SA, Puenpatom RA, Joo S, Ben-Joseph R and Summers KH.

Exposure to Potential CYP450 Pharmacokinetic Drug–Drug Interactions among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions. Pain Practice Article first published online: 28 DEC 2010

DOI: 10.1111/j.1533-2500.2010.00438.x

Leslie JB, Viscusi ER, Pergolizzi JV, and Panchal SJ.

Anesthetic Routines: The Anesthesiologist’s Role in GI Recovery and Postoperative Ileus Advances in Preventive Medicine Volume 2011, Article ID 976904, 10 pages

DOI: 10.4061/2011/976904

Pergolizzi F, Pergolizzi J III, Gan Z, Macario S, Pergolizzi JV, Ewin TJ, and Gan TJ.

Bullying in middle school: Results from a 2008 survey Int J Adolesc Med Health 2011; 23(1):11–18

Raffa RB, and Pergolizzi J.

The evolving understanding of the analgesic mechanism of action of flupirtine. Journal of Clinical Pharmacy and Therapeutics (2010) Article first published online: 28 NOV 2010

DOI: 10.1111/j.1365-2710.2010.01233.x

Müller-Schwefe, Jaksch W, Morlion B, Kalso E, Schafer M, Coluzzi F, Huygen F, Kocot-Kepska M, Mangas AC, Margarit C, Ahlbeck K, Orónska A, Mavrocordatos Collett B, Aldington , Nicolaou A, Pergolizzi J Varrassi G.

Commentary Make a CHANGE: optimizing communication and pain management decisions. Current Medical Research & Opinion Vol., No. , 2011, 1–8

Apfel C, Zhang K, George E, Shi S, Jalota L, Hornuss C, Fero K, Heidrich F, Pergolizzi J, Cakmakkaya O, and Kranke P.

Transdermal Scopolamine for the Prevention of Postoperative Nausea and Vomiting: A Systematic Review and Meta-Analysis Clinical Therapeutics. Vol. 32, No.12, 2010, 1-15.

Langley P, Mueller-Schwefe G, Nicolaou A, Liedgens H, Pergolizzi J, and Varrassi G.

The impact of pain on labor force participation, absenteeism and presenteeism in the European Union Journal of Medical Economics Vol. 13, No. 4, 2010, 662–672

Raffa, RB and Pergolizzi, JV.

Opioid Formulations Designed to Resist/Deter Abuse Drugs. 70(13):1657-1675, September 10, 2010

DOI: 10.2165/11537940-000000000-00000

Pergolizzi J, Labhsetwar S, Puenpatom A, Joo S, Ben-Joseph R, Summers K.

Prevalence of Exposure to Potential CYP450 Pharmacokinetic Drug – Drug Interactions among Patients with Chronic Low Back Pain Taking Opioids. Pain Practice Article first published online: 26 AUG 2010

DOI: 10.1111/j.1533-2500.2010.00413.x

Raffa RB and Pergolizzi, J.

Deciphering the mechanism(s) of action of natural products: analgesic peroxide oil as example In Press: Journal of Clinical Pharmacy and Therapeutics (2010).

Langley P, Muller-Schwerfe G, Liedgens H, Pergolizzi J, Varrassi G.

The societal impact of pain in the European Union: health-related quality of life and healthcare resource utilization Journal of Medical Economics Vol. 13, No. 3, 2010: 571-581

Raffa RB, Pergolizzi JV, and Tallarida RJ.

The Determination and Application of Fixed-Dose Analgesic Combinations for Treating Multimodal Pain The Journal of Pain, 2010: 11(8): 701-709

Apfel CC, Cakmakkaya OS, Martin W, Richmond C, Macario A, George E, Schaefer M and Pergolizzi JV.

Restoration of disc height through non-invasive spinal decompression is associated with decreased discogenic low back pain: a retrospective cohort study BMC Musculoskeletal Disorders 2010, 11:155

DOI: 10.1186/1471-2474-11-155

Raffa RB, Pergolizzi JV, Segarnick DJ and Tallarida RJ.

Oxycodone combinations for Pain Relief Drugs of Today 2010, 46(6): 379-398

Hochman JS, Pergolizzi J.

Cohort study finds nine times increased overdose risk (fatal plus non-fatal) in patients receiving 100 mg/day for 90 days compared with 1-20 mg/day opioids for chronic non-cancer pain, but wide CI and possibility of unmeasured confounders Evid Based Nurs. 2010; 13(2):55-6.

Arbuck D, Gharibo C, Labhsetwar S, Berdos F, Pergolizzi J

Management of Opioid Tolerability and Related Adverse Effects Journal of Medicine 2010; 3(1):1–10

Pergolizzi J, Pappagallo M, Raffa R, Gharibo C, Phillips R, Desjonquères S, and Tabor A.

Preliminary Observations of a Novel Topical Oil with Analgesic Properties for Treatment of Acute and Chronic Pain Syndromes Pain Practice 2010:3; 201-213

Morlion B, Pergolizzi J, Raffa R

European perspectives on upcoming analgesics: What do they have that we don’t—and what do they think about them? Techniques in Regional Anesthesia and Pain Management 2010:14; 86-98.

Pergolizzi J, Pappagallo M, Stauffer J, Gharibo C, Fortner N, De Jesus MN, Brennan MJ, Richmond C, Hussey D; The Integrated Drug Compliance Study Group (IDCSG).

The Role of Urine Drug Testing for Patients on Opioid Therapy Pain Pract. 2010; 10(6):497-507

Singla NK, Singla SK, Chung, F, Kutsogiannis DJ, Blackburn L, Lane SR, Levin J, Johnson B, Pergolizzi, J.

Phase II Study to Evaluate the Safety and Efficacy of the Oral Neurokinin-1 Receptor Antagonist Casopitant (GW679769) Administered with Ondansetron for the Prevention of Postoperative and Post discharge Nausea and Vomiting in High-risk Patients Anesthesiology 2010; 113:1–1

Varrassi G, Müller-Schwefe , Pergolizzi J , Orónska A, Morlion B, Mavrocordatos Margarit C, Mangas , Jaksch W, Huygen , Collett B, Berti M, Aldington, Ahlbeck K.

Pharmacological treatment of chronic pain – the need for CHANGE. Current Medical Research and Opinion 2010: 26(5): 1231-1245

Pergolizzi J and Raffa, R

The Use of High-Dose Transdermal Buprenorphine in the Treatment of Cancer Pain J. Med 2009; 2(2):111–120

Pergolizzi J, Raffa, R, and Gould, E.

Considerations on the use of oxymorphone in geriatric patients Expert Opin. Drug Saf. (2009) 8(5).

Pergolizzi J, Mercadante S, Virizuela Echaburuc A, Van den Eyndend B, de Farı´a Fragosoe RM, Mordarskif S, Lybaertg W, Beniakh J, Oron´ skai A, and Slamaj O.

The role of transdermal buprenorphine in the treatment of cancer pain: an expert panel consensus Current Medical Research and Opinion 25:6: 2009, 1517–1528

Gan TJ, Sinha A, Kovac A, Jones K, Cohen S, Battikha J, Deutsch J, and Pergolizzi, J.

A Randomized, Double-Blind, Multicenter Trial Comparing Transdermal Scopolamine Plus Ondansetron to Ondansetron Alone for the Prevention of Postoperative Nausea and Vomiting in the Outpatient Setting Anesth Analg 2009; 108:1498 –504

Pergolizzi J, Raffa R

Oxymorphone and Opioid Rotation Pan Medicine. 2009:10 ;( S1): S39-48

Pergolizzi J, Claybon L, Macario A, Richmond C.

Therapeutic Decision Support and the Management of Post-Operative Nausea and Vomiting J. Med 2009; 2(1):62-67

Groteke E, Pergolizzi J, Chicoine D.

The Quantification and Tracking of Osteoarthritis J. Med 2009; 2(1):23-29

Pergolizzi F, Richmond D, Gan Z, Macario S, Gan TJ, Richmond C, Pergolizzi J.

Two-Year Survey of Bullying in American Middle Schools J. Med 2009: 2(1); 45-51

Sinclair A, Pergolizzi J, Richmond C.

Patients Who Smoke: To Cut or Not to Cut J. Med 2009; 2(1):56-61

Pergolizzi J, Richmond C, Auster M, Florio F, Wilhelm J.

Non-surgical Spinal Decompression (DRX9000TM) for the Treatment of Chronic Low Back Pain – Case Report European Musculoskeletal Review, 2008; 3: 2, 58-60

Pergolizzi JV, Clair D, Richmond C.

Growth hormone replacement for adults: an overview. J Med. September 2008:9–15

Leslie JB, Pergolizzi JV, Macario A, Apfel C, Clair D, Richmond C, Florio, Auster M.

Prospective evaluation of the efficacy of spinal decompression via the DRX9000 for chronic low back pain J Med. September 2008:2–8.

Pergolizzi J, Yochum T, Florio F

Management of discogenic low-back pain with a non-surgical decompression system (DRX9000™)—Case Report US Musculoskeletal Review, 2008;1:14-15

Pergolizzi J, Florio F, Martin W.

Management of low-back pain with a non-surgical spinal decompression system (DRX9000™) – case report European Musculoskeletal Review, 2008; 3:1; 59–60

Pergolizzi J, Boger R, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa R, Sacerdote P.

Opioids and the Management of Chronic Severe Pain in the Elderly: Consensus Statement of an International Expert Panel with Focus on the Six Clinically Most Often Used World Health Organization step III Opioids (Buprenorphine, Fentanyl, Hydromorphone, Methadone, Morphine, Oxycodone Pain Practice June 2008.

Macario A, Richmond C, Auster M, and Pergolizzi J.

Treatment of 94 Patients with Chronic Discogenic Back Pain with the DRX9000: A Retrospective Chart Review Pain Practice. January 2008. Vol. 8, Issue 1 Page 11-17

Davis M., Madia V., Daeninck P., Pergolizzi J.

The emerging role of cannabinoid neuromodulators in symptom management. Support Care Cancer (2007) 15: 63–71

Macario A, Claybon L, and Pergolizzi J

Anesthesiologists’ practice patterns for rescue treatment of postoperative nausea and vomiting in the ambulatory PACU BMC Anesthesiology 2006:6:6

Macario, A. and Pergolizzi J

Systematic literature review of spinal decompression via motorized traction for chronic discogenic low back pain Pain Practice. September 2006.Vol. 6 Issue 3 Page 171-178

Macario A, Pergolizzi J.

Urine Drug Testing in Chronic Pain Patients Taking Opioids: A Clinical Practice Update The International Journal of Pain and Palliative Care 2005; 4(1): 133-9

Macario A, Pergolizzi J.

Pain and Nausea Management after Surgery The International Journal of Pain and Palliative Care 2004; 3: 91-100

Pergolizzi, J.

PONV Unplugged Seminars in Aesthesia, Perioperative Medicine and Pain, Vol 23, No 2 (June), 2004: pp 203-220

Ashkenazy, R, Pergolizzi, J, and Dobs, A.

Organizational model for a clinical trials unit within an academic medical center Research Practitioner Volume 2, Number 2 March/April 2001:107-112

Pergolizzi, J, Dobs A.

Essentials Elements of a Clinical Trials Unit/Center European Pharmaceutical Contractor. Feb 2000; 3: 96- 99

Pergolizzi, J, Auster M. Conaway G, Sardi A.

Cryosurgery for unresectable primary hepatocellular carcinoma: a case report and review of literature Am Surg. May 1999; 65(5): 402-405

Pergolizzi, J., Sardi, A, Pelzar, M.

Merkel Cell Carcinoma: An Aggressive Malignancy American Surgeon 5/97 Vol. 63 Page 450-454